Cryptococcosis Market, By Treatment (Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others), By Diagnosis (Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT Scan, Others), By End-Users (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI482421 | Publish Date: May 2024 | No. of Pages: 180

Global Cryptococcosis Market Companies

  • Johnson & Johnson Private Limited
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • Abbott
  • Glenmark Pharmaceuticals Limited
  • Bausch Health Companies Inc.
  • Sigmapharm Laboratories, LLC.
  • Astellas Pharma Inc.
  • MATINAS BIOPHARMA HOLDINGS, INC.
  • NuCare Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd
  • Gilead Sciences, Inc.
  • Jolly Healthcare
  • Bayer AG
  • GREENSTONE LLC
  • Citron Pharma
  • Hexal AG
  • Lunan Pharmaceutical Group
  • B.M. Pharmaceuticals
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Takeda Pharmaceutical Company Limited
  • Taj Pharmaceuticals Limited

Recent News:

  • In April 2022, Lupin Ltd completed the acquisition of a portfolio of brands from Anglo-French Drugs & Industries Limited (AFDIL) and its associates. The acquisition of the AFDIL brands takes the company further into shaping its portfolio to emerge as a leading pharmaceutical company in India.